Literature DB >> 32682369

Past and Present Behçet's Disease Animal Models.

Jermilia Charles1, Francis J Castellino1, Victoria A Ploplis1.   

Abstract

Behçet's disease (BD) is presumably an autoinflammatory disease of unknown etiology for which several animal models have been described over the years. Agents and methods used for the development of these models have ranged from the herpes simplex type one virus (hsv-1) pathogen to the use of transgenic mice. Other models have also been used to investigate a possible autoimmune component. Each model possesses its own unique set of benefits and shortcomings, with no one model fully being able to recapitulate the disease phenotype. Here, we review the proposed models and provide commentary on their effectiveness and usefulness in studying the disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Behçet’s disease (BD); Behçet’s disease animal models; autoimmune disease; herpes simplex viruszzm321990type 1; human leukocyte antigen; rare disease

Year:  2020        PMID: 32682369      PMCID: PMC7746599          DOI: 10.2174/1389450121666200719010425

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  129 in total

Review 1.  Epitope spreading: protection from pathogens, but propagation of autoimmunity?

Authors:  A M Powell; M M Black
Journal:  Clin Exp Dermatol       Date:  2001-07       Impact factor: 3.470

Review 2.  "The stress of dying": the role of heat shock proteins in the regulation of apoptosis.

Authors:  Helen M Beere
Journal:  J Cell Sci       Date:  2004-06-01       Impact factor: 5.285

3.  On the genetics of the Silk Route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Behçet's disease in an Iranian population.

Authors:  Raphael Carapito; Farhad Shahram; Sandra Michel; Marion Le Gentil; Mirjana Radosavljevic; Akira Meguro; Bahar Sadeghi Abdollahi; Hidetoshi Inoko; Masao Ota; Fereydoun Davatchi; Seiamak Bahram
Journal:  Immunogenetics       Date:  2015-05-05       Impact factor: 2.846

4.  Vasculo-Behçet disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET/CT).

Authors:  Makiko Yashiro Furuya; Jumpei Temmoku; Yuya Fujita; Naoki Matsuoka; Tomoyuki Asano; Shuzo Sato; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2019-07-20

Review 5.  Ophthalmic manifestations of rheumatologic disease: diagnosis and management.

Authors:  Carisa K Petris; Arghavan Almony
Journal:  Mo Med       Date:  2012 Jan-Feb

Review 6.  Bacterial Heat Shock Protein Activity.

Authors:  Farajollah Maleki; Afra Khosravi; Ahmad Nasser; Hamid Taghinejad; Mitra Azizian
Journal:  J Clin Diagn Res       Date:  2016-03-01

7.  The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.

Authors:  Ayşe İlksen Colpak; Umut Kalyoncu; Yasemin Gürsoy Özdemir
Journal:  Noro Psikiyatr Ars       Date:  2014-06-01       Impact factor: 1.339

8.  Expression of Th2 cytokines decreases the development of and improves Behçet's disease-like symptoms induced by herpes simplex virus in mice.

Authors:  S Sohn; E S Lee; H J Kwon; S I Lee; D Bang; S Lee
Journal:  J Infect Dis       Date:  2001-03-19       Impact factor: 5.226

9.  Recoverin is highly uveitogenic in Lewis rats.

Authors:  I Gery; N P Chanaud; E Anglade
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-07       Impact factor: 4.799

10.  Immunity to soluble retinal antigen in patients with uveitis accompanying juvenile rheumatoid arthritis.

Authors:  R E Petty; D W Hunt; D F Rollins; M L Schroeder; M L Puterman
Journal:  Arthritis Rheum       Date:  1987-03
View more
  1 in total

Review 1.  Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.

Authors:  Maria I Avrutsky; Carol M Troy
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.